Detalhe da pesquisa
1.
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
MMWR Morb Mortal Wkly Rep
; 73(16): 377-381, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662708
2.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep
; 72(24): 657-662, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319020
3.
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep
; 72(41): 1115-1122, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824423
4.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
MMWR Morb Mortal Wkly Rep
; 72(42): 1140-1146, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856366
5.
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
MMWR Morb Mortal Wkly Rep
; 71(31): 988-992, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925807
6.
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
MMWR Morb Mortal Wkly Rep
; 71(45): 1436-1441, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355612
7.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
MMWR Morb Mortal Wkly Rep
; 71(3): 90-95, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051137
8.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 416-421, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298454
9.
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
MMWR Morb Mortal Wkly Rep
; 71(26): 859-868, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771731
10.
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1344-1348, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555007
11.
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1545-1552, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735422
12.
Development of COVID-19 vaccine policy - United States, 2020-2023.
Vaccine
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158297
13.
Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies.
PLoS One
; 17(12): e0278624, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473010